Inactive Instrument

News Reata Pharmaceuticals, Inc.

Equities

RETA

US75615P1030

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments, Companies 2023 \| Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, Prokidney, and others.	Dec. 05	AQ
Reata Pharmaceuticals, Inc. Announces Management Changes	23-09-26	CI
Biogen Closes Reata Pharmaceuticals Acquisition	23-09-26	MT
Biogen Completes Acquisition of Reata Pharmaceuticals	23-09-26	AQ
Reata Pharmaceuticals, Inc.(NasdaqGM:RETA) dropped from NASDAQ Composite Index	23-09-26	CI
Biogen Inc. acquired Reata Pharmaceuticals, Inc..	23-09-25	CI
Reata Pharmaceuticals, Inc.(NasdaqGM:RETA) dropped from NASDAQ Biotechnology Index	23-09-25	CI
Reata Pharmaceuticals Shareholders Approve Buyout by Biogen	23-09-21	MT
Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.	23-09-21	BU
REATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA	23-08-28	BU
Insider Sell: Reata Pharmaceuticals	23-08-17	MT
Insider Sell: Reata Pharmaceuticals	23-08-17	MT
Insider Sell: Reata Pharmaceuticals	23-08-17	MT
Sanofi Reportedly Second Bidder for Reata	23-08-16	CI
French Stocks Flat as Traders Digest Key EU Economic Data	23-08-16	MT
Sanofi Lost Reata Pharmaceuticals to Biogen, Regulatory Filing Shows	23-08-16	MT
North American Morning Briefing : Stock Futures -2-	23-08-14	DJ
Reata Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
North American Morning Briefing : Investors Await -2-	23-08-07	DJ
REATA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA	23-08-02	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Reata Pharmaceuticals, Inc.

Equities

RETA

US75615P1030

Summary

Filters